Over 1,000 Cardiac Patients Treated with Genesis Robotic System
13. April 2023 09:06 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 13, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that over...
Broward Health Medical Center the First Hospital in Florida Using Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders
20. März 2023 08:08 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the grand...
Stereotaxis Reports 2022 Full Year Financial Results
03. März 2023 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 03, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis to Present at Cowen 43rd Annual Health Care Conference
21. Februar 2023 09:03 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
Stereotaxis to Report Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023
02. Februar 2023 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Corewell Health Grows Robotic Program to Treat Heart Rhythm Disorders with Adoption of Stereotaxis’ Genesis System
20. Dezember 2022 09:04 ET
|
Stereotaxis, Inc.
ST. LOUIS, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in robotic technologies for the treatment of cardiac arrhythmias, today announced the successful treatment of...
Stereotaxis to Participate in Piper Sandler 34th Annual Healthcare Conference
28. November 2022 09:07 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
Stereotaxis Reports 2022 Third Quarter Financial Results
10. November 2022 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis to Report Third Quarter Financial Results on November 10, 2022
20. Oktober 2022 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Receives St. Louis Mayor’s Innovation Award for 2022
03. Oktober 2022 09:16 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it was...